Subtypes and Triggers: Finding the 'Why'

While all cases of Sweet syndrome involve the same painful skin lesions, doctors divide the condition into three distinct “subtypes” based on what triggered the immune system’s reaction. Identifying your subtype is a vital part of your care, as it helps determine if you need further testing for underlying health conditions ^[1][2].

1. Classical Sweet Syndrome

This is the most common form and is usually “idiopathic,” meaning it occurs on its own or as a reaction to a temporary trigger ^[1]. It is most frequently seen in women between the ages of 30 and 60 ^[3]. Common triggers for the classical subtype include:

• Recent Infections: Often an upper respiratory infection (like a sore throat) or a gastrointestinal “stomach bug” that occurred 1 to 3 weeks before the rash appeared ^[4][1].
• Inflammatory Conditions: It is strongly linked to Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis. In many cases, the skin flare happens when the IBD is active ^[5][6].
• Pregnancy: Sweet syndrome can occasionally occur during pregnancy or in the period shortly after giving birth ^[7].
• Autoimmune Disorders: Conditions like rheumatoid arthritis, lupus, or sarcoidosis can also be associated with classical flares ^[8].

2. Drug-Induced Sweet Syndrome

In this subtype, a specific medication causes the immune system to overreact. The skin lesions typically appear abruptly—often in the days or weeks after you start the new drug ^[1][9]. While many drugs have been linked to the condition, some of the most common culprits include:

• Filgrastim (G-CSF): A medication used to boost white blood cell counts during chemotherapy ^[10][11].
• Azathioprine: An immunosuppressant often used for autoimmune diseases ^[9].
• Antibiotics: Specifically tetracyclines or trimethoprim-sulfamethoxazole ^[10].
• Other Medications: Certain heart medicines (furosemide, hydralazine) and anti-inflammatory drugs (celecoxib) ^[10].

If a drug is the cause, the skin may begin to clear once the medication is stopped, though steroids may still be needed ^[11]. Do not stop or restart an essential medication (such as chemotherapy, G-CSF, or immunosuppressants) without your prescriber’s advice. The medical team may need to substitute the medication or carefully treat the flare while you continue your therapy.

3. Malignancy-Associated Sweet Syndrome

In some people, Sweet syndrome acts as a “warning sign” for an internal cancer. While this can be a frightening thought, it is important to remember that most patients with Sweet syndrome do not have an underlying cancer. Identifying a link early, however, allows for prompt treatment of the underlying issue ^[12].

This subtype is most strongly associated with blood cancers, specifically Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ^[13][14]. Less commonly, it may be linked to solid tumors, such as breast, colon, or genitourinary cancers ^[13].

Screening and Evaluation

Because Sweet syndrome can appear months before a cancer is officially diagnosed, an individualized medical evaluation is recommended for adults with a new diagnosis. Your doctor will look for specific abnormalities in your blood work called cytopenias—levels of blood cells that are unusually low ^[13].

If no obvious trigger is found, your doctor may recommend monitoring your blood counts based on your individualized risk for up to 16 months ^[16]. This follow-up ensures that if an underlying condition is developing slowly, it is caught as early as possible.